Inhibition of human leucocyte collagenase by some drugs used in the therapy of rheumatic diseases.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001241:Aspirin / Q000494:pharmacology; D002417:Cattle; D003094:Collagen; D003520:Cyclophosphamide / Q000494:pharmacology; D004591:Electrophoresis, Polyacrylamide Gel; D005439:Flufenamic Acid / Q000494:pharmacology; D006046:Gold / Q000494:pharmacology; D006801:Humans; D006854:Hydrocortisone / Q000494:pharmacology; D006868:Hydrolysis; D006909:Hydroxyproline; D066298:In Vitro Techniques; D007213:Indomethacin / Q000494:pharmacology; D007962:Leukocytes / Q000201:enzymology*; D003012:Microbial Collagenase / Q000037:antagonists & inhibitors* / Q000097:blood / Q000302:isolation & purification / Q000378:metabolism; D010653:Phenylbutazone / Q000494:pharmacology; D011489:Protein Denaturation; D013885:Thiosulfates / Q000494:pharmacology; D014357:Trypsin
D000893:Anti-Inflammatory Agents; D013885:Thiosulfates; D005439:Flufenamic Acid; D006046:Gold; D003520:Cyclophosphamide; D003094:Collagen; D014357:Trypsin; D003012:Microbial Collagenase; D010653:Phenylbutazone; D001241:Aspirin; D006909:Hydroxyproline; D006854:Hydrocortisone; D007213:Indomethacin